Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Gso1g1085 ATGGACACCACTTCATCCCCTATGTCCCTCCAAACCCAAAAAACAAACTTTCAAGACCTTCCAGAAGCTTCCCCCAAGCCATACAAGAAGGGTATAGTGGCCACCCTAATGGGAGGAGCTGGTTCCTTCAAAGAAGACAACTATTTTGTGTCCCTTCTGAGATCCTCAGAGAAAAAGGCCCTTCAGGAGCTAAAAGAAAAGCTCAAGTCTTCATTTGAGGACTCTCCCTCTGATGCCTCCATGTGGGGCATTCCGCTCCTTGGAGGCGATGACAAAGCTGACGTCATCCTCCTCAAGTTCCTCAGAGCAAGGGACTTCAGGATTGGTGATGCACACCACATGCTCCTGAAGTGTTTATCTTGGAGGAAGGAGTTTGGTGCTGACACCATCTTGGAAGAGGATTTAGGGTTCAATAAGGAGCTTGAAGGGGTGGTGGCATACATGCAAGGGTATGACAAAGAAGGCCACCCTGTGTGCTACAATGCCTATGGGGTGTTCAAGGACAAGGAAATGTATGAAAGGGTCTTTGGTGATGAGGAGAAGCTGAAGAAGTTCCTAAGGTGGAGGGTTCAGGTTCTTGAGAGAGGCATCAAGGTGCTTCATTTCAAGCCTGGTGGGGTCAATTCCCTCATTCAGGTCACAGACCTCAAGGACATGCCAAAGAGAGAGCTTAGGGTGGCGTCCAACCAGATCCTCTCCTTGTTCCAAGACAACTACCCGGAAATGGTGGCTCGCAAGATTTTCATCAACGTGCCATGGTACTTCAGCATGTTGTATTCAATGTTCAGCCCGTTTCTGACTCAGAGAACCAAGAGCAAGTTTGTGATCTCTAAGGAAGGAAATGCTGCTGAGACACTCTACAAATTTATGAGACCTGAAGACATTCCTGTGCAGTATGGAGGACTGAATCGGCCCAGTGACTTGCAGAATGGTCCCCCAAAACCTGTATCTGAGTTCAGAATCAAAGGAGGGGAGAAAGTGAACATACAAATAGAAGGAATTGAGGCTGGTGCAACTATCACATGGGACATTGTAGTGGGAGGCTGGGACTTGGAATACAGTGCTGAGTTTGTGCCAAATGCTGAGGGAAGCTACACCATAGCAGTGGAGAAGCCAAGGAAAATGGGGGCATCGGAGGAAGCAATCCACAACTCATTCACATCAAAAGAATCTGGCAAAATGGTGCTCTCAGTTGACAACACTGCCTCAAGGAGGAAAAAGGTTGCTGCTTATCGCTATGTTGTACGCAAAAGCAGCACCATTTGA 1266 0.4779 MDTTSSPMSLQTQKTNFQDLPEASPKPYKKGIVATLMGGAGSFKEDNYFVSLLRSSEKKALQELKEKLKSSFEDSPSDASMWGIPLLGGDDKADVILLKFLRARDFRIGDAHHMLLKCLSWRKEFGADTILEEDLGFNKELEGVVAYMQGYDKEGHPVCYNAYGVFKDKEMYERVFGDEEKLKKFLRWRVQVLERGIKVLHFKPGGVNSLIQVTDLKDMPKRELRVASNQILSLFQDNYPEMVARKIFINVPWYFSMLYSMFSPFLTQRTKSKFVISKEGNAAETLYKFMRPEDIPVQYGGLNRPSDLQNGPPKPVSEFRIKGGEKVNIQIEGIEAGATITWDIVVGGWDLEYSAEFVPNAEGSYTIAVEKPRKMGASEEAIHNSFTSKESGKMVLSVDNTASRRKKVAAYRYVVRKSSTI* 422
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Gso1g1085 421 SUPERFAMILY CRAL/TRIO N-terminal domain 55 134 IPR036273 -
Gso1g1085 421 MobiDBLite consensus disorder prediction 1 20 - -
Gso1g1085 421 Pfam CRAL/TRIO, N-terminal domain 60 116 IPR011074 -
Gso1g1085 421 PANTHER PATELLIN-1 14 419 IPR044834 GO:0008289
Gso1g1085 421 Gene3D - 51 124 - -
Gso1g1085 421 SUPERFAMILY CRAL/TRIO domain 140 304 IPR036865 -
Gso1g1085 421 CDD SEC14 143 302 IPR001251 -
Gso1g1085 421 Pfam CRAL/TRIO domain 142 301 IPR001251 -
Gso1g1085 421 SMART sec14_4 140 304 IPR001251 -
Gso1g1085 421 SMART CRAL_TRIO_N_2 93 118 IPR011074 -
Gso1g1085 421 Gene3D - 129 313 IPR036865 -
Gso1g1085 421 Gene3D GOLD domain 314 415 - -
Gso1g1085 421 ProSiteProfiles GOLD domain profile. 283 417 IPR009038 -
Gso1g1085 421 MobiDBLite consensus disorder prediction 1 26 - -
Gso1g1085 421 PANTHER PATELLIN-6 14 419 - -
Gso1g1085 421 SUPERFAMILY Supernatant protein factor (SPF), C-terminal domain 318 417 IPR036598 -
Gso1g1085 421 ProSiteProfiles CRAL-TRIO lipid binding domain profile. 132 307 IPR001251 -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Gso1g1085 Gso-Chr1 44421871 44424875 Dispersed/Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Gso1g1085 97 296 Acyl Lipid Metabolism Gene Families AT1G55840 28.436 5.22e-15 73.6
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Gso1g1085 - - gmx:100809944 825.469
       

Event-related genes

Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Gso18g1678 18 48890203 48894091 Gso1g1085 1 44421871 44424875 PCT
Gso1g1085 1 44421871 44424875 Gso18g1678 18 48890203 48894091 PCT